How to use Atara Biotherapeutics Inc. ATRA as a Forecasting Tool ...

Atara Biotherapeutics (ATRA) came out with a quarterly loss of $2.93 per share ... estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based ...

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $21.9 million in its third quarter. On a per-share basis, the Thousand Oaks, ...

Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report ... an “outperform” rating and lowered their price target for the stock from $25.00 to $18.00 in a report on Friday, August 16th.

Analysts are estimating that Atara Biotherapeutics will report an earnings per share (EPS) of $-1.93. Atara Biotherapeutics ...

The 36-month beta value for ATRA is at 0.45. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 as “hold,” and 0 as “sell.” The public float ...

Yatra Online, Inc. (YTRA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.02 per share a year ago. These figures ...

Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.” The public float for ATRA is 3.97M, and at present, short sellers hold a 16.10% ...